Myesha Lacy
Keine laufenden Positionen mehr
Profil
Myesha Lacy worked as a VP of Investor Relations & Corporate Communications at Global Blood Therapeutics, Inc. and Adverum Biotechnologies, Inc. before obtaining an undergraduate degree from Holy Names University.
Ehemalige bekannte Positionen von Myesha Lacy
| Unternehmen | Position | Ende |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Investor Relations Kontakt | - |
| ADVERUM BIOTECHNOLOGIES, INC. | Investor Relations Kontakt | - |
Ausbildung von Myesha Lacy
| Holy Names University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
